HIV

Zidovudine can decrease HIV transmission by 70% in non-breastfed babies.

Women are more likely to contract HIV from infected men.

Mother-to-child HIV transmission drives pediatric AIDS incidence, and risk of transmission increases as the mother's viral load increases.

Efficacy of Truvada varies by gender in HIV treatment.

The annual rate of 50,000 new HIV infections has not dropped in over a decade.

Pharmacy owner charged with paying patients hundreds of dollars in cash in exchange for not receiving their prescription medications.

A pharmacist has been arrested for allegedly defrauding New York's Medicaid program by billing for high-cost HIV medications that were never actually dispensed.

Study finds reducing inflammation carries the added benefit of improving cognition among patients with HIV.

Special considerations must be made when treating patients infected with both HIV and hepatitis C virus.

Beaming of X-rays at immobilized molecules could lead to new methods to fight HIV and retrovirus-based cancers.

New approach could prevent bone loss induced by antiretroviral therapy in HIV patients.

The American Journal of Health-Systems Pharmacists recently published an update to its guidelines on pharmacist involvement in HIV care.

Highly active antiretroviral therapy has dramatically curtailed HIV transmission and AIDS mortality.

Approximately 2.3 million people worldwide are infected with both HIV and hepatitis C virus.

While students on spring break are eagerly enjoying some fun in the sun," they're more likely to participate in binge drinking, engage in casual sex, and fall victim to alcohol-related injuries.

New formulation of Isentress shows similar efficacy to currently available twice-daily formulation for the HIV therapy.

New once-daily formulation of Isentress shows similar efficacy to the currently approved twice-daily formulation of the HIV treatment.

ASHP has published new guidelines on pharmacist involvement in HIV care in the April 1 edition of AJHP, ASHP's peer-reviewed, scholarly publication.

Discovery may lead to significant new HIV treatments.

Children of mothers who took atazanavir showed slightly decreased scores on language and social-emotional development.

Odefsey can be used as a replacement for antiretroviral therapy in HIV-positive patients who are virologically-suppressed.

Odefsey is the smallest single tablet regimen to treat patients 12-years-old and above infected with HIV.

This case is the first reported failure for pre-exposure prophylaxis to stop HIV infection.

The FDA has approved emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg as a new treatment for HIV-1 infection in certain patients.

A gay man has been infected with HIV despite taking Truvada every day for 2 years.